NanoLogix, Inc. (NNLX)

Market Cap	163.00
Revenue (ttm)	1.27K +139.0%
Net Income	-1.95M
EPS	-0.02
Shares Out	162.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,924,270
Open	0.000001
Previous Close	n/a
Day's Range	0.000001 - 0.000001
52-Week Range	0.000001 - 0.0051
Beta	-99.36
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NanoLogix

NanoLogix, Inc., a biotechnology company, provides diagnostics of viable microorganisms and viruses. It offers rapid viral assay test, which is a method for detection and quantification of a virus; and N-assay diagnostics that furnish the ability to detect and identify bacteria and other microorganisms for pharmaceutical, industrial, veterinary, and environmental testing, as well as microbiology, soil microbiology and bioremediation, microbial physiology, pharmacology, pharmaco-kinetics, and antibiotic sensitivity sectors. The company sells its...

• Industry: Biotechnology
• Sector: Healthcare
• CEO: Bret Barnhizer
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: NNLX

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 21, 2026

Data Sources Report a data error